Olson William C 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 22, 2011
Insider Transaction Report
Form 4
Olson William C
VP, Research & Development
Transactions
- Sale
Common Stock
2011-06-21$7.11/sh−106$754→ 44,974 total - Sale
Common Stock
2011-06-21$7.09/sh−2,766$19,605→ 45,080 total
Footnotes (1)
- [F1]Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer.